Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 40,209 | 47,019 | 48,877 | 41,603 | 49,028 |
| Operating Income | -40,209 | -47,019 | -48,877 | -41,603 | -49,028 |
| Interest Expense | 2,541 | 2,450 | 2,345 | 2,202 | 1,922 |
| Other Income | 1,276 | 532 | 1,185 | -32 | -3,066 |
| Pre-tax Income | -41,474 | -48,937 | -50,037 | -43,837 | -54,016 |
| Income Tax | -2,826 | -24,051 | 677 | -664 | -141 |
| Net Income Continuous | -38,648 | -24,886 | -50,714 | -43,173 | -53,875 |
| Net Income | $-38,648 | $-24,886 | $-50,714 | $-43,173 | $-53,875 |
| EPS Basic Total Ops | -0.40 | -0.26 | -0.53 | -0.45 | -0.57 |
| EPS Basic Continuous Ops | -0.40 | -0.26 | -0.53 | -0.45 | -0.57 |
| EPS Diluted Total Ops | -0.40 | -0.26 | -0.53 | -0.45 | -0.57 |
| EPS Diluted Continuous Ops | -0.40 | -0.26 | -0.53 | -0.45 | -0.57 |
| EBITDA(a) | $-39,971 | $-46,782 | $-48,788 | $-41,567 | $-48,993 |